Jason Chen

Chen is a cofounder of Verge Genomics, which is using artificial intelligence and machine learning to accelerate the early phases of the drug discovery process. His research, which has been published in multiple journals, is aimed at finding fruitful targets for therapies in neurodegenerative diseases.